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There is a relative dearth of studies examining the cognitive and neuropsychiatric features of
black Alzheimer's disease (AD) patients in the United States. Therefore, this cross-sectional
investigation reported on the prevalence and clinical correlates of depression and psychosis in
a community-dwelling black AD sample. The study participants comprised 55 English-speaking
black patients evaluated consecutively at a university-affiliated memory disorders clinic. All
patients were evaluated utilizing standardized procedures and diagnosed with possible or
probable AD according to the criteria established by the National Institute of Neurological and
Communicative Diseases and Stroke-Alzheimer's Disease and Related Disorders Association.
The presence of neuropsychiatric symptoms, including major depression and psychosis (delu-
sions or hallucinations) was established via a semistructured psychiatric interview with the patient
and primary care giver. The level of global cognitive impairment was rated with the Mini-Mental
State Examination. The results showed that major depression and psychosis were observed in
20% and 58% of the sample, respectively. Mood disturbance was linked with low education,
whereas psychosis was associated with greater cognitive dysfunction. This study provides
important insight into the clinical characteristics of community-dwelling black AD patients. It is
clear that continued research in the area of ethnicity and dementia is warranted to better
understand the clinical needs of blacks and other minority populations in the United States that
are afflicted with AD. (J Natl Med Assoc. 2000;92:424-429.)
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Alzheimer's disease (AD) has been identified as
the most common cause of dementia among the
black, Hispanic, and non-Hispanic white popula-
tions in the United States."2 Hallmark clinical fea-
tures of the disease include a gradual onset and
progressive rate of decline in cognitive skills as well
as marked functional deficits. Current estimates sug-
gest that AD affects nearly 4 million Americans and
this number is projected to rise to 14 million by the
middle of the next century.3'4 Hence, the economic
burden of AD in this country is expected to be
substantial over the coming decades.5
In addition to deficits in cognitive and functional
performance, AD patients may also evidence dra-
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matic neuropsychiatric changes. Some of the more
common behavioral and psychological signs and
symptoms among patients with dementia include
depression and psychosis (i.e., delusions or halluci-
nations).6,7 These symptoms have significant clinical
implications for the patients as well as the family
care givers. For instance, research indicates that
neuropsychiatric symptoms may impact the clinical
course of the disease8'9 and frequently lead to care
giver distress1'0"' and greater risk of patient institu-
tionalization.12
Although early investigations focused primarily
on the profound cognitive deficits of the disease,
more recent research has documented the spec-
trum of neuropsychiatric problems in AD patients.
Yet, research efforts have failed to reflect the cul-
tural diversity of the United States population.'3
Indeed, a review of the literature indicates a relative
paucity of empirical studies focusing on ethnicity
and dementia.'4 With respect to behavioral pathol-
ogy, the prevalence of depression and psychosis in
black AD patients has not been clearly established.
Furthermore, it remains to be elucidated what spe-
cific factors are related to psychiatric disturbances
in these patients. Because blacks are currently the
largest minority group in the U.S.,'5 investigations
of behavioral and psychological signs and symptoms
in this patient population are imperative.
The current study addressed several specific
questions: 1) What are the prevalence rates for the
syndromes of major depression and psychosis
among black AD outpatients? 2) What factors show
relations with' mood disturbance and psychotic
symptomatology in this patient population? In light
of prior research among Caucasian'6-'8 and black
AD patients,'9'20 we chose to evaluate whether the
following factors conferred risk for behavioral pa-
thology in the current sample: age, education, gen-
der, cognitive status, and comorbid psychosis/de-
pression.
METHODS
Participants
The participants for this cross-sectional study
were drawn from a consecutive series of 94 elderly
black patients evaluated betwveen 1987 and 1999 at
the Wien Center for Alzheimer's Disease and Mem-
ory Disorders, an affiliated outpatient clinic of
Mount Sinai Medical Center and the University of
Miami School of Medicine. Demographic informa-
tion, including patient ethnicity, was ascertained
during the intake evaluation with the patient and
primary care giver. We chose to classify the patients
as black rather African American for the purposes
of this study, because the current investigation in-
cluded subjects of African origin who were born in
either the United States or the Caribbean. To focus
on a more homogeneous black cohort, we restricted
the sample to blacks that spoke English as their
primary language. Thus, French or Creole-speaking
patients of Haitian heritage (n = 4) and Spanish-
speaking patients of Hispanic heritage (n = 8) were
excluded from the study. Twenty-seven additional
patients were not included in the present investiga-
tion due to incomplete clinical data (e.g., did not
undergo comprehensive psychiatric assessment).
The final sample comprised 55 English-speaking
black patients.
The study participants underwent a comprehen-
sive multidisciplinary clinical evaluation, in addition
to a thorough assessment that included complete
blood count, chemistry panel, serology, serum thy-
roid-stimulating hormone, vitamin B12 levels, and
computerized tomography (CT) or magnetic reso-
nance imaging (MRI) of the brain. All of the pa-
tients met diagnostic criteria for possible or proba-
ble AD as established by the National Institute of
Neurological and Communicative Diseases and
Stroke-Alzheimer's Disease and Related Disorders
Association.21 The sensitivity of a clinical diagnosis
ofAD at the Wien Center has previously been shown
to be 75% for possible AD and 93% for probable
AD.22 Participation in the investigation was volun-
tary, and informed consent was obtained by the
patient or primary care giver for all cases. The pro-
tocol was approved by the Human Rights Commit-
tee at Mount Sinai Medical Center, Miami Beach,
FL.
Clinical Assessment
The assessment of patient depression was part of
an extensive psychiatric evaluation conducted by
clinicians specializing in dementia. The informants
for this study were the primary care givers who
accompanied the patients to the clinic. Diagnoses of
major depression were made in accordance with the
criteria established by the Diagnostic and Statistical
Manual of Mental Disorders, Third Edition-Revised.23
Symptoms of psychosis (evidence of delusions or
hallucinations) over the past month were assessed
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Table 1.
Clinical and Demographic Characteristics in Black
Alzheimer's Disease Patients
Characteristic Mean ± SD
Age 76.4 + 7.9
Age of disease onset 71.9 + 8.2
Education 9.3 + 4.4
Mini-Mental State Exam Score 12.8 + 6.1
Major depression N (%)
Yes 11 (20%)
No 44 (80%)
Psychosis
Yes 32 (58%)
No 23 (42%)
Gender
Male 10(18%)
Female 45 (82%)
using a structured clinical interview previously de-
scribed.24 Delusions were defined as a fixed, false
belief not attributable to the patient's cultural ex-
perience. These were distinguished from disorien-
tation, confabulation, or overvalued ideas. Halluci-
nations were carefully differentiated from illusions.
Psychiatric information ascertained from the clini-
cal interview was used to arrive at a multidisciplinary
consensus diagnosis, with the presence of major
depression and psychosis recorded in the patient's
discharge summary (Table 1).
The Mini-Mental State Examination (MMSE)25
was administered to assess level of global cognitive
impairment. This scale contains 11 items that test
attention, calculation, recall, language, praxis, reg-
istration, and orientation. The MMSE has a maxi-
mum score of 30 points, with scores less than 24
suggesting significant cognitive dysfunction. This in-
strument demonstrates satisfactory reliability and
construct validity as a brief screen of global cogni-
tive functioning.2"
Statistical Analysis
The assessment of factors associated with major
depression and psychosis was determined utilizing
multiple logistic regression analyses that yielded
odds ratios (OR) and 95% confidence intervals (CI)
for the explored risk factors. Putative risk factors for
each psychiatric outcome included age, education,
gender, comorbid psychosis/depression, and level
of global cognitive dysfuinction (MMSE score).
Table 2.
Risk Factors for Major Depression in Black Alzheimer's
Disease Patients
95% Cl
Predictor OR Lower Upper p value
Age 0.90 0.79 1.00 0.08
Education 1 .31 * 1 .06 1 .73 0.03
Gender 2.45 0.32 51.40 0.45
Cognitive status 0.90 0.75 1 .05 0.22
Psychosis 0.88 0.45 5.04 0.88
*OR corresponds to each one-point decrement in years of
schooling.
RESULTS
Patient Characteristics
In this sample, the mean age for patients was 76.4
years (SD, 7.9) and the mean age of oniset was 71.9
years (SD, 8.2). The average years of formal educa-
tion was 9.3 (SD, 4.4). Eighty-two percent (n = 45)
of the participants in the study were women. Partic-
ipants had an average MMSE score of 12.8 (SD, 6.1).
The prevalence rates for the explored neuropsychi-
atric syndromes were 20% (n = 11) for major de-
pression and 58% (n = 32) for psychosis.
Factors Associated with Depression and
Psychosis in AD
Table 2 presents the results of the logistic regres-
sion analysis for imajor depression. An elevated risk
for mood disturbance was associated with fewer
years of formal education (OR = 1.31; 95% CI =
1.06 to 1.73; Wald X2 = 4.9; p < 0.05). It should be
noted that, because educatioin was entered as a con-
tinuous variable in the analysis, each increment in
the OR corresponds to a 1-year change in years of
schooling. This analysis did not showN, an increased
risk for depression in relation to patient age, gen-
der, level of cognitive impairment, and comorbid
psychosis.
The findings of the logistic regressioni analysis for
psychosis are listed in Table 3. Increased risk for
thought disturbance was predicted by greater cog-
nitive dysfunction (OR = 1.21; 95% CI = 1.07 to
1.40; Wald x2 = 7.5; p < 0.05). As described previ-
ously, the OR corresponds to each one-point decre-
ment in MMSE score, because this predictor was
entered as a continuous variable in the analysis. The
logistic regression analysis indicated that patient
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Table 3.
Risk Factors for Psychosis in Black Alzheimer's Disease
Patients
95% Cl
Predictor OR Lower Upper p value
Age 1.05 .97 1.16 .26
Education 0.95 0.80 1.13 .58
Gender 1.06 0.21 5.05 .94
Cognitive status 1.21 * 1.07 1.40 .01
Major Depression 0.93 0.20 4.59 .93
*OR corresponds to each one-point decrement in the Fol-
stein Mini-Mental State Exam score.
age, education, gender, and comorbid depression
did not increase the risk for psychosis.
DISCUSSION
This study provides important insight into the
prevalence and associated factors of depression and
psychosis among community-dwelling black AD pa-
tients. We found that 20% of the sample evidenced
major depression. This finding is generally consis-
tent with prior reports of affective disturbance in
dementia, which have shown prevalence rates of
12%-16% in black patients' 2'20'27'28 and 10%-20%
in Caucasian patients.'6"17 It should be noted that
studies that have focused on depressive symptoms
rather than the syndrome of depression in black
dementia patients have reported higher rates, ranging
from 24% to 44%.192930 The results also indicated
that 58% of the sample presented with psychotic symp-
tomatology. This rate compares favorably with the re-
sults of previous research among black dementia pa-
tients that have reported rates of 15%-77% for
thought disturbance.'9,20'27,29-33 The frequency of psy-
chosis in our sample of black AD patients is also in
accordance with prior studies in Caucasian AD co-
horts, which have shown prevalence rates of 10%-73%
for delusions and 21%-49% for hallucinations.'6"18
The average MMSE score in our cohort of black
outpatients was 12.8, indicating the sample was
functioning at the moderate to severe stages of de-
mentia. The observed MMSE scores are very similar to
those reported in other studies ofcommunity-dwelling
black AD patients from around the United States,
which have ranged fromn 13.4 to 17.7.1,19,29,30,33 As
noted by Auchus,19 this suggests that the dementia
syndrome for many of these patients was not identi-
fied until they had progressed to a rather significant
stage of the illness. It is evident that an implication of
this finding is the need to develop more effective
outreach strategies to facilitate the early diagnosis and
treatment of AD among community-dwelling blacks.
This is particularly relevant given the recent develop-
ment of pharmacologic agents for AD that may im-
prove cognitive functioning in the mild-to-moderate
stages of the illness.34-36 Pharmacologic treatments
may also be effective in terms of ameliorating symp-
toms of behavioral pathology in these patients.36-38
The current investigation examined factors asso-
ciated with signs and symptoms of depression and
psychosis. In this sample of black AD patients, in-
creased risk for mood disturbance was linked with
lower education. This finding contrasts with a re-
cent report of black AD outpatients from Atlanta,
GA, which found a higher frequency of affective
symptoms among patients with more education.'9
The discrepant findings may be related to method-
ological differences between the two studies, be-
cause Auchus'9 rated symptoms of depressed or
anxious affect whereas we identified more severe
major depressive disorders. The relation of educa-
tion with affective disturbance has not been exten-
sively investigated in demented patients, although
several other studies have reported elevated depres-
sion in AD patients with fewer years of formal edu-
cation.39'40 A likely explanation for this relationship
may be that education represents a surrogate for
socioeconomic status, which has been linked with
heightened risk for depressive symptoms among
older adults.4'
We found that more severe cognitive dysfunction
increased the risk for psychosis. This finding is con-
gruent with reports of psychosis in AD42,43 and a
recent study of demented African American nursing
home residents.20 The association between psychi-
atric symptoms and MMSE scores is likely related to
neuropathological changes underlying the global
cognitive dysfunction witnessed among patients
with AD. F6rstl and colleagues,44 for instance, re-
ported that in a sample of 56 autopsy-confirmed AD
patients, delusions and hallucinations were linked
with lower cell counts in the dorsal raphe nucleus.
In addition, Zubenko and coworkers45 found that,
among 27 autopsy-verified AD cases, psychosis was
associated with increased densities of senile plaque
and neurofibrillary tangles in the prosubiculum and
middle frontal cortex areas of the brain. These stud-
ies support the contention that neuropathologic
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mechanisms mediate the relation between cognitive
impairmnent and behavioral manifestations in AD.
There are several limiitations to the present inves-
tigation. The results may not characterize black AD
patients in general, because this study included
black patients of U.S. and Caribbean descent (iden-
tified as English-speaking) cturrently living in south
Florida. However, the decision to include U.S.-born
and Caribbean-born blacks seems justified given the
lack of substantial clinical and psychiatric differ-
ences that have been demonstrated between these
two groups in sttudies of demented outpatients3"
and deimented nursing home residents.2"'28 Given
the paucity of psychiatric research among ethnic
minority elderly, further research is needed to iden-
tify not only interracial but also intraracial differ-
ences in the expression of behavioral pathology
among patients with AD. Indeed, Fabrega and col-
leagues4"1 note that "even a biologically well-defined
black grouip is likely to contain subjects that are
infltlenced by highly diverse (background) cultures
(and national traditions) so that it naturally does
not constitute a well-established 'cultural' group (p.
286).
In suinmary, this study adds to the growing body
of literature on ethlnicity and dementia. We found
that depressioni and psychosis represent prominent
neturopsychiatric syndromes among black AD pa-
tients residing in the comminunity. Several of the
explored factors were shown to confer risk for be-
havioral pathology, incltuding lower education and
increased cognitive imipairnment. Continued investi-
gations of the prevalence and clinical correlates of
behavioral and psychological disturbances amnong
black AD patients are requiired to understand the
clinical needs of this patient population. The find-
ings of such research may also promote more in-
formned outreaclh strategies and lead to the inmple-
men tation of appropriate psychopharmacologic
and behavioral interventions.
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